SEC Form 5 · accession 0001570523-18-000016
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Dec 31, 2017
Accepted (ET)
Mar 30, 2018 · 3:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Jun 14, 2016 | P | 5,000 | $0.15 | A | 20,800,359 | D | |
| Common stock | Jun 14, 2016 | P | 1,000 | $0.164 | A | 20,800,359 | D | |
| Common stock | Jun 14, 2016 | P | 1,000 | $0.164 | A | 20,800,359 | D | |
| Common stock | Jun 14, 2016 | P | 500 | $0.1635 | A | 20,800,359 | D | |
| Common stock | Jun 14, 2016 | P | 500 | $0.1635 | A | 20,800,359 | D | |
| Common stock | Jun 14, 2016 | P | 1,000 | $0.1635 | A | 20,800,359 | D | |
| Common stock | Jun 14, 2016 | P | 1,000 | $0.1635 | A | 20,800,359 | D | |
| Common stock | Jun 14, 2016 | P | 1,000 | $0.1635 | A | 20,800,359 | D | |
| Common stock | Jun 15, 2016 | P | 5,000 | $0.163 | A | 20,800,359 | D | |
| Common stock | Jun 15, 2016 | P | 1,000 | $0.178 | A | 20,800,359 | D | |
| Common stock | Jun 15, 2016 | P | 5,100 | $0.175 | A | 20,800,359 | D | |
| Common stock | Jun 15, 2016 | P | 1,000 | $0.17 | A | 20,800,359 | D | |
| Common stock | Jun 15, 2016 | P | 500 | $0.17 | A | 20,800,359 | D | |
| Common stock | Jun 15, 2016 | P | 3,053 | $0.169 | A | 20,800,359 | D | |
| Common stock | Jun 15, 2016 | P | 1,947 | $0.169 | A | 20,800,359 | D | |
| Common stock | Jun 15, 2016 | P | 500 | $0.1762 | A | 20,800,359 | D | |
| Common stock | Jun 15, 2016 | P | 400 | $0.1762 | A | 20,800,359 | D | |
| Common stock | Jun 15, 2016 | P | 100 | $0.1775 | A | 20,800,359 | D | |
| Common stock | Jun 15, 2016 | P | 500 | $0.178 | A | 20,800,359 | D | |
| Common stock | Jun 15, 2016 | P | 4,000 | $0.1779 | A | 20,800,359 | D | |
| Common stock | Jun 15, 2016 | P | 500 | $0.178 | A | 20,800,359 | D | |
| Common stock | Jun 16, 2016 | P | 1,000 | $0.175 | A | 20,800,359 | D | |
| Common stock | Jun 16, 2016 | P | 500 | $0.172 | A | 20,800,359 | D | |
| Common stock | Jun 17, 2016 | P | 5,000 | $0.1777 | A | 20,800,359 | D | |
| Common stock | Jun 17, 2016 | P | 1,000 | $0.18 | A | 20,800,359 | D | |
| Common stock | Jun 17, 2016 | P | 500 | $0.184 | A | 20,800,359 | D | |
| Common stock | Jun 17, 2016 | P | 500 | $0.184 | A | 20,800,359 | D | |
| Common stock | Jun 17, 2016 | P | 5,000 | $0.183 | A | 20,800,359 | D | |
| Common stock | Jun 17, 2016 | P | 5,000 | $0.185 | A | 20,800,359 | D | |
| Common stock | Jun 17, 2016 | P | 5,000 | $0.185 | A | 20,800,359 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This is part 12 of 16 submissions.